|
The Aaron’s Company, Inc. is a leading, technology-enabled, omni-channel provider of lease-to-own (“LTO”) and purchase solutions of furniture, appliances, consumer electronics, and accessories. Since its founding in 1955, Aaron’s has been committed to serving the overlooked and underserved customer with a dedication to inclusion and improving the communities in which it operates. Through our portfolio of approximately 1,300 stores and our Aarons.com e-commerce platform, we provide consumers with LTO and purchase solutions for the products they need and want, with a focus on providing our customers with unparalleled customer service and an attractive value proposition, including competitive monthly payments and total cost of ownership as compared to other LTO providers, high approval rates, and lease plan flexibility. In addition, we offer a wide product selection, free prompt delivery, product setup, service and returns, and the ability to pause, cancel or resume lease contracts at any time with no penalty to the customer. As of December 31, 2021, the Company had 1,074 Company-operated stores in 43 states and Canada, and 236 independently-owned franchised stores in 35 states and Canada.
2-24-2022 |
Mr. Douglas A. Lindsay
Chief Executive Officer The Aaron's Company Inc 400 Galleria Parkway SE Suite 300 Atlanta, GA 30339-3182 United States 678 402 3000 https://www.aarons.com NYSE Stock Symbol AAN |
|
Acuity Brands, Inc. (referred to herein as “we,” “our,” “us,” the “Company,” or similar references) is a market-leading industrial technology company. We use technology to solve problems in spaces and light. Through our two business segments, Acuity Brands Lighting and Lighting Controls (“ABL”) and the Intelligent Spaces Group (“ISG”), we design, manufacture, and bring to market products and services that make the world more brilliant, productive, and connected. We achieve growth through the development of innovative new products and services, including lighting, lighting controls, building management systems, and location-aware applications.
10-27-2021 |
Mr. Neil M. Ashe
Chairman Acuity Brands, Inc 1170 Peachtree Street, N.E. Suite 2300 Atlanta, GA 30309 United States 404-853-1400 http://www.acuitybrands.com NYSE Stock Symbol AYI |
|
Aflac Incorporated (the Parent Company) was incorporated in 1973 under the laws of the state of Georgia. The Parent Company and its subsidiaries (collectively, the Company) provide financial protection to more than 50 million people worldwide. The Company’s principal business is supplemental health and life insurance products with the goal to provide customers the best value in supplemental insurance products in the United States (U.S.) and Japan. When a policyholder or insured gets sick or hurt, the Company pays cash benefits fairly and promptly for eligible claims. Throughout its 65 year history, the Company’s supplemental insurance policies have given policyholders the opportunity to focus on recovery, not financial st
2-23-2022 |
Mr. Daniel Paul Amos
Chairman Aflac Incorporated 1932 Wynnton Road Columbus, GA 31999 United States 706-323-3431 http://www.aflac.com NYSE Stock Symbol AFL |
|
We are a leading manufacturer and distributor of agricultural equipment and related replacement parts throughout the world. Our purpose is to provide farmer-focused solutions to sustainably feed our world. We sell a full range of agricultural equipment, including tractors, combines, self-propelled sprayers, hay tools, forage equipment, seeding and tillage equipment, implements, and grain storage and protein production systems. Our products are widely recognized in the agricultural equipment industry and are marketed under a number of well-known brands, including: Challenger®, Fendt®, GSI®, Massey Ferguson® and Valtra®, supported by our Fuse® precision agriculture solutions. We distribute most of our products through approximately 3,200 independent dealers and distributors in approximately 140 countries. We also provide retail and wholesale financing through our finance joint ventures with Coöperatieve Rabobank U.A., which we refer to as “Rabobank.”
2-25-2022 |
Mr. Eric P. Hansotia
Chairman AGCO Corporation 4205 River Green Parkway Duluth, GA 30096 United States 770-813-9200 http://www.agcocorp.com NYSE Stock Symbol AGCO |
|
Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. Our only commercial product is ILUVIEN®, an intravitreal implant that treats patients by delivering a continuous microdose of the corticosteroid fluocinolone acetonide (FAc) in the eye, for up to 36 months. “Intravitreal” refers to the space inside the eye behind the lens that contains the jelly-like substance called vitreous. ILUVIEN was initially developed to treat diabetic macular edema (DME), a disease of the retina that affects individuals with Type 1 or Type 2 diabetes and can lead to severe vision loss and blindness. ILUVIEN is also used in certain countries in the EEA to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). Uveitis is an inflammatory disease of the uveal tract, which is comprised of the iris, ciliary body and choroid, that can lead to severe vision loss and blindness.
3-23-2022 |
Mr. Richard S. Eiswirth Jr.
Chief Executive Officer Alimera Sciences, Inc 6120 Windward Parkway Suite 290 Alpharetta, GA 30005 United States 678-990-5740 http://www.alimerasciences.com NASDAQ Stock Symbol ALIM |
|
Asbury Automotive Group, Inc., a Delaware corporation organized in 2002, is a Fortune 500 company and the 6th largest franchised automotive retailer in the United States. Our mission and vision is to put guest experience as our “North Star” and be the most guest-centric automotive retailer in the industry. We follow three key principles to guide us: (1) foster a fun and supportive culture where team members thrive personally, while building meaningful bonds with one another; (2) be great ambassadors and exceptional stewards of capital for our partners who fuel our mission; and (3) be caring professionals who strive to delight our guests and foster love for the brand. Our strong organizational culture and purposeful mission allows us to continuously deliver best-in-class experiences to our guests. As of December 31, 2021, we owned and operated 205 new vehicle franchises, representing 31 brands of automobiles at 155 dealership locations, 35 collision centers, seven stand-alone used vehicle dealerships, one used vehicle wholesale business and one auto auction within fifteen states. Our store operations are conducted by our subsidiaries
3-01-2022 |
Mr. David W. Hult
Chief Executive Officer Asbury Automotive Group, Inc. 2905 Premiere Parkway, NW Suite 300 Duluth, GA 30097 United States 770-418-8200 http://www.asburyauto.com NYSE Stock Symbol ABG |
|
We are a geographically diversified homebuilder with active operations in 13 states within three geographic regions in the United States: the West, East, and Southeast. Our homes are designed to appeal to homeowners at different price points across various demographic segments and are generally offered for sale in advance of their construction. Our objective is to provide our customers with homes that incorporate extraordinary value and quality, at affordable prices, while seeking to maximize our return on invested capital over the course of a housing cycle.Beazer Homes USA, Inc. was incorporated in Delaware in 1993. Our principal executive offices are located at 1000 Abernathy Road, Suite 260, Atlanta, Georgia 30328, and our main telephone number is (770) 829-3700. We also provide information about our company, including active communities, through our Internet website located at www.beazer.com. Information on our website is not a part of this Form 10-K and shall not be deemed incorporated by reference.
11-10-2021 |
Mr. Allan P. Merrill
Chairman Beazer Homes USA, Inc 1000 Abernathy Road Suite 260 Atlanta, GA 30328 United States 770-829-3700 http://www.beazer.com NYSE Stock Symbol BZH |
|
We are a technology company that develops, sells and services interactive solutions predominantly for the global education market, but which are also sold into the health, government and corporate sectors. We are seeking to become a worldwide leading innovator and integrator of interactive products and software for schools, as well as for business and government learning spaces. We currently design, produce and distribute interactive technologies including flat panels, projectors, whiteboards and peripherals for the education market. We also distribute science, technology, engineering and math (or “STEM”) products, including our portable science lab. All products are integrated into our classroom software suite that provides tools for whole class learning, assessment and collaboration. To date, we have generated substantially all revenue in the U.S. from the sale of interactive displays and related software to the educational market. In the region encompassing Europe, the Middle East and Africa (collectively,” EMEA”), approximately 92% of our revenues relate to the education sector and the remainder comes from health, government and corporate including the banking and financial services sector.
4-13-2022 |
Mr. Michael Ross Pope
Chairman Boxlight Corporation 1045 Progress Circle Lawrenceville, GA 30043 United States 866-972-1549 www.boxlightcorp.com Nasdaq Stock Symbol BOXL |
|
Our company’s mission is to redefine marketing by using data for good. We work to accomplish this mission by operating an advertising platform within our own and our partners' digital channels, which include online, mobile applications, email, and various real-time notifications (the "Cardlytics platform"). We also operate a customer data platform which utilizes point-of-sale ("POS") data, including product-level purchase data, to enable marketers, in a privacy-protective manner, to perform analytics and targeted loyalty marketing and also enable marketers to measure the impact of their marketing (the "Bridg platform"). The partners for the Cardlytics platform are predominantly financial institutions ("FI partners") who provide us with access to their anonymized purchase data and digital banking customers. The partners for the Bridg platform are merchants ("merchant data partners") who provide us with access to their POS data, including product-level purchase data. By applying advanced analytics to the purchase data we receive, we make it actionable, helping marketers identify, reach and influence likely buyers at scale, and measure the true sales impact of their marketing spend. We have strong relationships with leading marketers across a variety of industries, including retail, restaurant, travel and entertainment, direct-to-consumer, and grocery and gas.
3-01-2022 |
Mr. Scott D. Grimes
Chairman Cardlytics, Inc 675 Ponce de Leon Avenue NE Suite 6000 Atlanta, GA 30308 United States 888-798-5802 http://www.cardlytics.com Nasdaq Stock Symbol CDLX |
|
We are the largest branded marketer in North America of apparel exclusively for babies and young children. We own two of the most highly recognized and most trusted brand names in the children’s apparel industry, Carter’s and OshKosh B’gosh (or “OshKosh”). Our brand portfolio also includes Skip Hop, a leading baby and young child lifestyle brand, exclusive Carter’s brands developed for specific wholesale customers, and little planet, a brand focused on organic fabrics and sustainable materials.
2-25-2022 |
Mr. Michael D. Casey
Chairman Carter's, Inc Phipps Tower 3438 Peachtree Road Suite 1800 NE Atlanta, GA 30326 United States 678-791-1000 http://www.carters.com NYSE Stock Symbol CRI |
|
We are a biopharmaceutical company focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, or SCS. Our novel SCS injection platform, utilizing our proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Our SCS injection platform can be used in conjunction with existing drugs designed for delivery to the SCS, novel therapies and future therapeutic innovations. We believe our proprietary suprachoroidal administration platform has the potential to become a standard for delivery of therapies intended to treat chorioretinal diseases.
3-11-2022 |
Dr. George M. Lasezkay
Chief Executive Officer Clearside Biomedical, Inc 900 North Point Parkway Suite 200 Alpharetta, GA 30005 United States 678-270-3631 http://www.clearsidebio.com Nasdaq Stock Symbol CLSD |